AGF Investments Inc’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

AGF Investments Inc’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-198,892	Closed	-$23.1M	–	820
2019 Q4	$23.1M	Sell	198,892 -16,196	-8%	-$1.88M	0.28%	111
2019 Q3	$24.6M	Buy	+215,088	New	+$21.4M	0.31%	104
2017 Q3	–	Sell	-163,920	Closed	-$18.5M	–	389
2017 Q2	$18.5M	Sell	163,920 -4,595	-3%	-$514K	0.21%	128
2017 Q1	$16.9M	Buy	168,515 +47,852	+40%	+$5.11M	0.18%	143
2016 Q4	$13M	Sell	120,663 -10,472	-8%	-$1.22M	0.15%	159
2016 Q3	$16.3M	Sell	131,135 -2,110	-2%	-$249K	0.18%	147
2016 Q2	$14.2M	Buy	133,245 +133,131	+116,782%	+$15.5M	0.16%	152
2016 Q1	$13K	Buy	+114	New	+$13.4K	﹤0.01%	420

Other funds holding CBPO

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

SGCM

Sand Grove Capital Management London, United Kingdom $444M AUM 131.11% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

AGF Investments Inc's CBPO Position: Q1 2020 in Review

AGF Investments Inc sold out of China Biologic Products Holdings, Inc. (CBPO) in Q1 2020, closing a stake of 198,892 shares — an estimated $23.1M sold.

AGF Investments Inc first reported a position in CBPO in Q1 2016 and held it in 8 quarters. The position peaked at $24.6M in Q3 2019. 84 funds tracked by Wall St. Rank hold CBPO as of Q1 2020.

AGF Investments Inc reported no remaining China Biologic Products Holdings, Inc. position as of Q1 2020 after selling out during the quarter.
AGF Investments Inc sold 198,892 China Biologic Products Holdings, Inc. shares in Q1 2020, an estimated $23.1M.
AGF Investments Inc first reported a position in China Biologic Products Holdings, Inc. in Q1 2016 and held it in 8 quarters.
AGF Investments Inc's China Biologic Products Holdings, Inc. position peaked at $24.6M in Q3 2019.
84 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2020.

Based on AGF Investments Inc's 13F filing for Q1 2020, filed 8 May 2020.